Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

This study has been terminated.
(Limited efficacy response observed at 1/3 enrollment at investigated dosage.)
Sponsor:
Information provided by (Responsible Party):
Dompé s.p.a.
ClinicalTrials.gov Identifier:
NCT01571895
First received: April 4, 2012
Last updated: June 25, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)